Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference42 articles.
1. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial;Tepe;Circulation,2015
2. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease;Rosenfield;N Engl J Med,2015
3. 1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon;Sachar;JACC Cardiovasc Interv,2021
4. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial;Dake;Circulation,2016
5. Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trail;Gouëffic;Circulation,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High-Dose Drug-Coated Balloon Versus Polymer-Based Drug-Eluting Stent for Femoropopliteal Artery Disease Treatment;Journal of Endovascular Therapy;2024-08-15
2. Association between statin intensity and femoropopliteal stent primary patency in peripheral arterial disease;CVIR Endovascular;2024-08-03
3. Association between Statin Intensity and Femoropopliteal Stent Primary Patency in Peripheral Arterial Disease;2024-07-18
4. Directional atherectomy with anti-restenotic therapy versus open repair in patients with restenotic disease after surgical revascularization of the common femoral artery;The Journal of Cardiovascular Surgery;2024-07
5. Safety and Effectiveness of Debulking for the Treatment of Infrainguinal Peripheral Artery Disease. Data From the Recording Courses of vascular Diseases Registry in 2910 Patients;Angiology;2024-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3